These novel treatments, Retatrutide, represent a significant advancement in addressing obesity and conceivably other disorders. These drugs are categorized as GLP-1 pathway stimulators, meaning they to mimic the body's GLP-1 hormone , enhancing glucose release and lowering appetite . Despite Tirzepatide each one functions largely similarly, they ar